Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Psychiatry Research|January 1, 1988
Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissueC N Svendsen, C C Hrbek, M Casendino, et al.Cell Transplantation|April 28, 2000
Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's diseaseR J Armstrong, C Watts, C N Svendsen, et al.Annals of Neurology|October 1, 1986
Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, C N Svendsen, et al.Neuroscience|November 1, 1996
Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged ratsS De Lacalle, J D Cooper, C N Svendsen, et al.Brain Research. Developmental Brain Research|April 18, 1997
Restricted growth potential of rat neural precursors as compared to mouseC N Svendsen, J Skepper, A E Rosser, et al.Neuroreport|November 4, 1996
GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral graftsS R Sinclair, C N Svendsen, E M Torres, et al.Nature Biotechnology|May 1, 2001
Growth factors regulate the survival and fate of cells derived from human neurospheresM A Caldwell, X He, N Wilkie, et al.European Journal of Pain (London, England)|December 15, 2012
Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled studyT Ostenfeld, A Krishen, R Y Lai, et al.Annals of Neurology|September 1, 1986
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, G K Chattha, et al.Endocrinology|June 1, 1991
Computer-assisted mapping of immunoreactive mammalian gonadotropin-releasing hormone in adult human basal forebrain and amygdalaE G Stopa, E T Koh, C N Svendsen, et al.Pageof 6